Urticaria Voices: Real-World Treatment Patterns and Outcomes in Chronic Spontaneous Urticaria
Despite H1-antihistamine switching and up-dosing, most patients (84%) had inadequately controlled disease. Approximately one-quarter of inadequately controlled patients were escalated to more effective treatments such as biologics. These results suggest a need for additional treatment options for patients with inadequately controlled CSU to provide sustained symptom relief.
Authors
- Pallavi Prakash Saraswat (ORCID: https://orcid.org/0000-0002-4374-9543)
- Nadine Chapman‐Rothe
- Tonya Winders (ORCID: https://orcid.org/0000-0001-7689-6438)
- Jessica McCarthy (ORCID: https://orcid.org/0000-0002-5771-2274)
- Karsten Weller (ORCID: https://orcid.org/0000-0003-4437-0313)
- Jonathan A. Bernstein (ORCID: https://orcid.org/0000-0002-3476-1196)
- Tara C. Raftery
Institutions
- Novartis (Switzerland) (CH)
- Humboldt-Universität zu Berlin (DE)
- Novartis (India) (IN)
- Bernstein Clinical Research Center (US)
- Novartis (United States) (US)
- Novartis (Ireland) (IE)
- University of Cincinnati (US)
- Freie Universität Berlin (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- Dermatology and Therapy
- Published
- 2025-06-22
- DOI
- https://doi.org/10.1007/s13555-025-01461-8
- Citations
- 1
- Primary Topic
- Urticaria and Related Conditions
- Type
- article
- Field-Weighted Citation Impact
- 1.67
Funders
- Asthma and Allergy Foundation of America